Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
ROC
Product Overview
Alternative Name:
Ulipristal acetate (UPA) Oral
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Oral
Duration Type:
Short-acting
Description:
An estrogen-free, daily low dose oral progesterone receptor modulators, ulipristal acetate (UPA).
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
ulipristal acetate
Potential Multi-Purpose Technology (MPT):
No
Regimen:
daily
Duration:
daily
Partner:
HRA Pharma
,
NICHD
Status
Project Phase:
Late Development
Project Stage:
Phase II
Status Details:
A phase II clinical trial is ongoing under the auspices of the NICHD Contraceptive Clinical Trials Network.
Programmatic Considerations
Additional Information
Additional Information:
HRA Pharma website
Download Product Report
